SCHEMBL5374326

SCHEMBL5374326

O=C1CCCCCCCCCCC1O

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.52
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CA4 P22748 2/20 0.48
MCL1 Q07820 1/20 0.39
CA6 P23280 1/20 0.39
HTT P42858 1/20 0.38
ALDH1A1 P00352 1/20 0.36
TRIM24 O15164 1/20 0.36
TRIM33 Q9UPN9 1/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
TLR4 O00206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16334939 1.00
SCHEMBL2197061 1.00 KMT2A (0.52) KMT2ACA1CA2CA4MCL1
SCHEMBL6339497 1.00 KMT2A (0.52) KMT2ACA1CA2CA4MCL1
SCHEMBL2196978 1.00 KMT2A (0.52) KMT2ACA1CA2CA4MCL1
SCHEMBL2196708 1.00 KMT2A (0.52) KMT2ACA1CA2CA4MCL1
SCHEMBL2196254 1.00 KMT2A (0.52) KMT2ACA1CA2CA4MCL1
SCHEMBL2196757 1.00 KMT2A (0.52) KMT2ACA1CA2CA4MCL1
SCHEMBL2864371 1.00 KMT2A (0.52) KMT2ACA1CA2CA4MCL1
SCHEMBL2195150 1.00 KMT2A (0.52) KMT2ACA1CA2CA4MCL1
SCHEMBL11354182 1.00 KMT2A (0.52) KMT2ACA1CA2CA4MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1430012-A2 METHOD FOR MAKING A SUBSTANTIALLY PURE MIXTURE OF CYCLODODECANEDIOL ISOMERS AND USES THEREOF INVISTA Technologies S.à.r.l. (US) 2004-06-23 EP claimed
US-20030069455-A1 Method for making a substantially pure mixture of cyclododecanediol isomers and uses thereof INVISTA NORTH AMERICA S.A.R.L. (F/K/A ARTEVA NORTH AMERICA S.A.R.L.) 2003-04-10 US claimed
WO-2003027052-A2 METHOD FOR MAKING A SUBSTANTIALLY PURE MIXTURE OF CYCLODODECANEDIOL ISOMERS AND USES THEREOF E. I. DU PONT DE NEMOURS AND COMPANY (US) 2003-04-03 WO claimed
CN-112166098-B Method for the continuous production of ketones from epoxides in a fixed bed 赢创运营有限公司 2023-03-28 CN disclosed
CN-115304471-A Preparation method of long carbon chain dicarboxylic acid 中国天辰工程有限公司 2022-11-08 CN disclosed
EP-1329448-B2 Procsess for producing laurolactam from cyclododecanone UBE INDUSTRIES (JP) 2021-08-04 EP disclosed
US-11034640-B1 Method for the continuous production of ketones from epoxides in a fixed bed EVONIK OPERATIONS GMBH (DE) 2021-06-15 US disclosed
US-20210163392-A1 Method for the continuous production of ketones from epoxides in a fixed bed EVONIK OPERATIONS GMBH (DE) 2021-06-03 US disclosed
CN-112166098-A Method for the continuous production of ketones from epoxides in a fixed bed 赢创运营有限公司 2021-01-01 CN disclosed
EP-3596035-B1 METHOD FOR THE CONTINUOUS PRODUCTION OF KETONES FROM EPOXIDES IN A FIXED BED EVONIK OPERATIONS GMBH (DE) 2020-08-26 EP disclosed
WO-2019233938-A1 METHOD FOR THE CONTINUOUS PRODUCTION OF KETONES FROM EPOXIDES IN A FIXED BED EVONIK DEGUSSA GMBH (DE) 2019-12-12 WO disclosed
US-20030139596-A1 Process for producing laurolactam from cyclododecanone UBE INDUSTRIES, LTD. (JP) 2003-07-24 US disclosed
EP-1329448-A1 Procsess for producing laurolactam from cyclododecanone Ube Industries, Ltd. (JP) 2003-07-23 EP disclosed
US-20030069455-A1 Method for making a substantially pure mixture of cyclododecanediol isomers and uses thereof INVISTA NORTH AMERICA S.A.R.L. (F/K/A ARTEVA NORTH AMERICA S.A.R.L.) 2003-04-10 US disclosed
WO-2003027052-A2 METHOD FOR MAKING A SUBSTANTIALLY PURE MIXTURE OF CYCLODODECANEDIOL ISOMERS AND USES THEREOF E. I. DU PONT DE NEMOURS AND COMPANY (US) 2003-04-03 WO disclosed
US-5098707-A Thioimidazolium salts as anticoagulants for platelet aggregation inhibitors MERCK & CO., INC. (US) 1992-03-24 US disclosed
US-5030644-A Thrombolytic, fibrinolytic therapy MERCK & CO., INC. (US) 1991-07-09 US disclosed
EP-0411705-A1 Imidazole compounds and their use as transglutaminase inhibitors MERCK & CO. INC. (US) 1991-02-06 EP disclosed
US-4883910-A OXIDATION OF CYCLIC COMPOUNDS TO ACYCLIC DIACIDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-11-28 US disclosed
EP-0115582-A2 Use of cyclododecen-2-on as a perfuming agent and process for its preparation HÜLS AKTIENGESELLSCHAFT (DE) 1984-08-15 EP disclosed